heart attack Myocardial infarction
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Informed consent Men and women aged 40-70 years For active groups, regular physical active (i.e. aerobic exercise such as running >=3 times a week), for at least 20 years For MI groups, myocardial infarction within the past 5 years
Exclusion criteria
Exclusion criteria: Smokers Type I or II diabetes mellitus Other diseases that interfere with exercise testing For subject in non-MI groups: - hypercholesterolemia - hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vascular structure and function (conduit artery endothelial function, conduit artery diameter, blood flow, IMT, conduit and resistance artery structure, peak hypereamic blood flow, exercise-induced vasodilation) Plaque vulnerability by ultrasoiund and serum biomarkers (hs-CRP, SAA, IL-6, MMP-9, MMP-2, TIMP-1, TIMP-2) Cardiac structure and function (cardiac mass and dimensions, systolic and diastolic function parameters, left and right ventricle strain rate) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objectives include groups comparisons of physical fitness and traditional risk factors, i.e. cholesterol, lipid profile, HbA1C, insulin sensitivity, blood pressure, and waist circumference. Two extra blood samples will be drawn and stored for future analyses (if no objection participant), in case relevant CVD genetic candidates become available. | — |
Countries
Netherlands